Regenerative biosensor chips based on switchable mutants of avidin—A systematic study  by Zauner, Dominik et al.
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a  b  s  t  r  a  c  t
Biotinylated  bait  molecules  can  be immobilized  on biotinylated  sensor  chips  by  formation  of
biotin–avidin–biotin  bridges  which  are  very  stable  when  using  wild-type  (strept)avidin.  Stable  immo-
bilization  of  biotinylated  baits  is  important  for monitoring  reversible  binding  and  dissociation  of  prey
molecules.  For  measurements  with  another  bait  molecule,  however,  it is  desirable  to replace  all  immo-
bilized  proteins  by  fresh  (strept)avidin  and  new  biotinylated  bait.  In  this  study,  ﬁve  avidin  mutants
have  been  characterized  with  respect  to  their  ability  to  form  switchable  biotin–avidin–biotin  bridges
on  biotinylated  chip  surfaces,  as needed  for  complete  chip  regeneration.  All ﬁve  mutants  formed  stableiotin surface
vidin mutant
eversible immobilization
ensor chip regeneration
biotin–avidin–biotin  bridges  at pH  7, were more  or less  stable  at pH  2–3, and  required  the  combination
of pH  2 with  SDS  for quantitative  removal  from  the  chip  surface.  Mutant  #3 (“switchavidin”)  showed  the
best  combination  of  properties,  i.e.,  low  nonspeciﬁc  adsorption  of  protein  and  nucleic  acids, high binding
capacity,  and  good  stability  at pH 2–3, as  typically  used  for quantitative  removal  of  prey  molecules  in
repeated  measurement  cycles.
© 2016  The  Authors.  Published  by Elsevier  B.V. This  is  an open  access  article  under  the  CC BY  license. Introduction
Biosensors monitor binding of soluble prey molecules to immo-
ilized bait molecules. Subsequently, all bound prey molecules
ust be removed before the next sample can be measured [1].
sually the bait molecules are immobilized by covalent bonds or
y avidin–biotin interaction [2–5]. Since neither is reversible in a
easonable time window, a new measurement series can only be
tarted after exchanging the sensor chip and immobilizing another
ait molecule. A desirable alternative is replacement of the old
ait molecules for new ones. Exchange of the bait on the chip
onfers signiﬁcant advantages: (i) it saves the cost and time of
hip exchange. (ii) No human intervention is required, allowing for
witching of baits in programmed overnight runs. (iii) It eliminates
hip-to-chip variation, which is a problem with some product lines.
iv) The most urgent need for in-situ exchange of bait molecules
s encountered if the harsh conditions (e.g., 100 mM HCl or NaOH)
∗ Corresponding author.
E-mail address: hermann.gruber@jku.at (H.J. Gruber).
ttp://dx.doi.org/10.1016/j.snb.2016.02.039
925-4005/© 2016 The Authors. Published by Elsevier B.V. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
typically used for removal of bound prey molecules [1] cause denat-
uration of the bait.
In order to be useful in practical application, any method of bait
exchange must obey strict criteria: (a) the bait must remain stably
bound for hours or days, until all planned measurements have been
completed with one kind of bait molecule. (b) It must be possible to
quantitatively remove all bound bait molecules within minutes. (c)
The binding capacity for new bait molecules must be fully retained
for a large number of regeneration cycles. (d) The reagents used
for chip regeneration must be compatible with the ﬂow cells of
common biosensors. (e) The reagents and the chip surface must be
stable under ambient conditions (i.e., not sensitive to oxidation or
hydrolysis). (f) The sensor surface used for switchable bait immobi-
lization must not bind any prey or side components of the sample.
(g) Preferably, the method should be easy to implement in many
types of biosensors.
Two published methods fulﬁll these criteria to a high degree. In
both methods, avidin or (strept)avidin is reversibly immobilized,
providing for immobilization of biotinylated bait molecules before
a measurement series, and for rapid removal of (strept)avidin
plus bait at the end. In the ﬁrst method, (strept)avidin is
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Fig. 1. Reversible functionalization of biotinylated sensor chips with biotinylated probe molecules. (a) Illustration of chip recycling with switchable biotin–avidin–biotin
bridges. (b) Testing of different avidin mutants for reversible immobilization of biotinylated antibodies. (c) SPR traces showing binding of mutant #1 in both ﬂow cells and
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he  mutant layers in both cells, biotin–IgG bound in FC2, and baseline drift from s
eferences to color in this ﬁgure legend, the reader is referred to the web  version of
eversibly immobilized on carboxymethyldextran via DNA
ouble strand formation (BIAcore application note “Biotin CAPture
it”, GE data ﬁle 28-9577-47 AA, https://www.gelifesciences.com/
ehcls images/GELS/Related%20Content/Files/1314787424814/
itdoc28957747AA1 20110831132219.pdf). This method fulﬁlls
riteria (a)–(e) but it is not applicable to DNA-binding proteins and
nly available for one brand of biosensors. In the second method,
he avidin mutant M96H is used as a switchable link between
iotinalyted sensor surfaces and biotinylated bait molecules [6,7].
utation M96H is located at the subunit interface (Supplementary
ig. S1) and it confers sensitivity to low pH [8]. In the biotin-bound
tate, however, this mutant retains full function down to pH
.7, unless avidin M96H is intentionally dissociated into four
onfunctional subunits by combination of citric acid with sodium
odecyl sulfate (SDS) as outlined in Fig. 1a [6].An obvious drawback of avidin M96H is its positive charge at
eutral pH (pI ∼ 9.5, see Fig. 1e). Most proteins and all nucleic
cids are negatively charged at neutral pH, resulting in nonspeciﬁc
dsorption to immobilized avidin M96H, especially in case of DNAers 1–4 in (c) correspond to the stages 1–4 in (b). (d) Comparison with respect to
 to 4. (e) Calculated pI of the avidin mutants (Table S1). (For interpretation of the
rticle.)
[6,7]. Nonspeciﬁc protein adsorption was largely suppressed by
blocking with biotin–BSA [6], whereas suppression of DNA adsorp-
tion required additional mutations, which lowered the pI towards
7 (mutant #3 in Fig. 1e and Table S1) [7].
In the present study, ﬁve avidin mutants (Table S1 and Fig.
S1) were characterized along criteria (a)–(g) and the limits of
the method were identiﬁed. Mutant #3 (“switchavidin” [7]) was
found to be the optimal choice, combining high stability of the
biotin–avidin–biotin bridge with low nonspeciﬁc adsorption of
protein and DNA.
2. Materials and methods
2.1. MaterialsThe avidin mutants were constructed for bacterial expression
in Escherichia coli by introducing mutations to cDNA encod-
ing chicken avidin containing ompA signal peptide in pET101/D
[9,10] by QuikChange mutagenesis according to manufacturer’s
6  Actua
i
P
o
c
t
R
i
T
w
N
G
f
w
6
w
a
c
c
b
g
t
3
b
p
3
l
t
t
2
I
s
g
a
w
u
o
r
s
t
d
2
a
i
[
s
d
(
1
w
r
3
s
m
s
o
r
a48 D. Zauner et al. / Sensors and
nstructions (Stratagene, La Jolla, CA, USA) or by using standard
CR techniques, where multiple mutations were introduced by
verlapping mutated DNA fragments ampliﬁed using DNA oligonu-
leotides containing the desired mutations, followed by subcloning
o pET101/D with the help of TOPO cloning (for details see
ef. [7]). All DNA constructs were conﬁrmed by DNA sequenc-
ng. The proteins were produced and puriﬁed as described [7].
he components of the mixed self-assembled monolayer (SAM)
ere synthesized and mixed as described in Ref. [6]. Biotin-cap-
HS, biotinylated protein G (biotin–protein G), immunoglobulin
 (IgG) from goat, human IgG2, and lysozyme were obtained
rom Sigma–Aldrich. Bovine serum albumin (BSA, fatty acid-free)
as purchased from Roche Applied Science. Biotin–IgG (with
–7 biotins/IgG) was prepared as published [11] and biotin–BSA
as prepared using the same mass concentrations of protein
nd biotin-cap-NHS. All single-stranded DNA molecules were
ustom-synthesized by VBC Genomics (Vienna) with 99 ± 0.5%
oupling efﬁciency and the uncapped ﬁnal product was puriﬁed
y HPLC (positive selection for the 5′-terminal dimethoxytrityl
roup by reversed phase chromatography). The biotin-probe had
he structure 5′-biotin-GCACCTGACTCCTGTGGAGAAGTCTGCCGT-
′ [5], the “unlabeled probe” had the same sequence but lacked
iotin. The digoxigenin-labeled analyte was complementary to the
robe (digoxigenin-5′-ACGGCAGACTTCTCCACAGGAGTCAGGTGC-
′) and the “unlabeled analyte” had the same sequence but
acked digoxigenin [5]. Biotin-N19T contained 1:1:1:1 mix-
ures of A:C:G:T in positions 1–19 and thymine in posi-
ion 20.
Phosphate-buffered saline (PBS 7.3) contained 140 mM NaCl,
.7 mM KCl, 10 mM Na2HPO4, and 1.8 mM KH2PO4, yielding pH 7.3.
t was degassed by sterile ﬁltration (0.2 m)  with strong aspirator
uction every day.
Biotin–BSA, Biotin–IgG, BSA, IgG, and lysozyme were puriﬁed by
el ﬁltration in PBS 7.3 on Superdex 200 (1 × 30 cm,  GE Healthcare)
t 0.5 ml/min to remove aggregates. The protein concentrations
ere adjusted to 1 mg/ml  and small aliquots were frozen in liq-
id nitrogen and stored at −25 ◦C. Biotin–protein G, IgG2 and the
ligonucleotides were dissolved in PBS (20 M,  7 M,  and 10 M,
espectively) and stored at −25 ◦C. The aliquots were thawed by
hort immersion in water (∼20 ◦C), diluted to the desired concen-
ration by addition of PBS 7.3, stored at 4 ◦C, and used within four
ays.
.2. Surface plasmon resonance experiments
Cleaning of bare glass chips, evaporation of chromium (3 nm)
nd gold (41 nm), as well as cleaning of the gold surface and coat-
ng with a mixed biotin SAM (Fig. S2) was performed as described
6]. The chips were mounted on the chip supports with double-
ided adhesive tape (non-permanent) and inserted in a BIAcore X
evice for measurement of binding by surface plasmon resonance
SPR). Degassed buffer (PBS 7.3) was run over the chip surface at
0–20 l/min, as stated in the ﬁgure legends. The resonance angle
as recorded at 1 s intervals in both ﬂow cells and expressed in
esonance units (1 RU = 0.0001◦).
. Results and discussion
Fig. 1a shows the two kinds of chip regeneration used in this
tudy. “Normal regeneration” means quantitative removal of prey
olecules only, as conventionally performed on all kinds of biosen-ors [1]. “Rigorous regeneration” means quantitative dissociation
f the biotin–avidin–biotin bridges on the chip surface, thereby
ecovering the bare biotinylated chip on which fresh avidin and
 new kind biotinylated bait is immobilized for a new series oftors B 229 (2016) 646–654
experiments. In this study, we  examined the reproducibility of chip
regeneration (Section 3.1), nonspeciﬁc binding of protein (Section
3.2) and nucleic acids (Section 3.6), multivalent bait–prey inter-
actions (Section 3.3), as well as perfect differentiation between
sample cell and reference cell (Section 3.5). Of particular inter-
est was  the suitability of methods for quantitative removal of prey
(“normal regeneration”) without losing biotinylated bait molecules
from the chip surface (Section 3.4).
3.1. Binding of biotinylated protein to biotinylated surfaces by
using different avidin mutants
In preceding studies [6,7], three different avidin mutants were
shown to provide for reversible formation of biotin–avidin–biotin
bridges, as outlined in Fig. 1a. Reversibility is made possible by
mutation M96H which is located at the subunit interface (Fig. S1),
causing subunit dissociation when treated with SDS/citric acid [6].
Mutant #2 contains the additional mutation R114L which low-
ers the pI value, reduces nonspeciﬁc binding, and enhances the
afﬁnity for biotinylated molecules [7], due to its location next to
the biotin-binding site (Fig. S1). The three additional mutations
in mutant #3 are located on the outer surface of avidin (Fig. S1,
Table S1) and shifted the pI value towards 7 (Fig. 1e), result-
ing in very low nonspeciﬁc adsorption of proteins and nucleic
acids [7].
In the present study, the newly prepared avidin mutant #4 was
analogous to mutant #3, except that mutation R114L was replaced
by mutation R26N which had little effect on the pI value (Fig. 1e).
The intention was to demonstrate the beneﬁcial effect of muta-
tion R114L for the stability of the biotin-bound state, and this was
conﬁrmed by the data (see below). Finally, mutant #5 contained
all mutations at the same time, causing further lowering of the pI
value (Fig. 1e, Table S1).
Mutants #1–5 were systematically tested for their performance
in reversible biosensor functionalization. The ﬁrst test concerned
binding of the avidin mutants to the biotinylated chip and of
biotin–IgG on top of avidin (stages 2 and 3 in Fig. 1b), as well
as removal of the bound proteins with a mixture of SDS  and cit-
ric acid (stage 4 in Fig. 1b). As exempliﬁed in Fig. 1c, the avidin
mutant was  injected in both ﬂow cells and biotin–IgG in FC2
only. The experiments were performed in triplicates with all ﬁve
avidin mutants and the signal amplitudes were highly reproducible
(Fig. 1d).
The extent of mutant binding (stage 2 minus stage 1) was similar
for mutants #1–4 (∼2000 RU, circles in Fig. 1d), only mutant #5 was
less effective. Binding of biotin–IgG (stage 3 minus stage 2) showed
a signiﬁcant decrease with increased mutant number (triangles in
Fig. 1d). All mutants allowed for good reversibility of binding (stage
4 minus stage 1, squares in Fig. 1d). Mutant #3 performed best
in this respect, with a drift of 13 ± 18 RU in FC1 and 13 ± 14 RU in
FC2.
It is important to note that all tested chips could be regenerated
for an unlimited number of cycles, except that the binding capac-
ity of the chips started to decrease after three weeks of continued
use.
3.2. Nonspeciﬁc adsorption of protein on monolayers of different
avidin mutants
Sensitive and selective biosensing implies that no bind-
ing/adsorption of any component of the sample occurs on the chip
surface, except for speciﬁc capture of prey to bait. Fig. 2a exempli-
ﬁes the standard test [6] which consists of consecutive injections
of lysozyme, BSA, and goat IgG.
The results for BSA and IgG are summarized in Fig. 2b. Mutant
#3 showed the lowest adsorption of BSA (circles) and IgG (trian-
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Fig. 2. Non-speciﬁc adsorption of proteins on monolayers of the avidin mutants #1–5. (a) Test for protein adsorption to mutant #2. (b) The experiment in (a) was performed
with  mutants #1–5. The amounts of protein which remained bound at the end of the injections of BSA and goat IgG are shown. “BSA injection 2” and “IgG after BSA” for
mutants #1–3 were reported before [7].
Fig. 3. Kinetics of human IgG2 binding to biotin–protein G on top of mutant #3. (a) Schematic of binding to immobilized protein G in FC1 (red trace in (c)). (b) Schematic
of  the control injection in FC2 (blue trace in (c)). (c) Repeated association and dissociation of IgG2, using 100 mM glycine (pH 2.7) for removal of IgG2. The different IgG2
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famples were prepared by serial dilution of 7 M IgG2 (in PBS 7.3) with sample bu
inding curves (solid traces in (d) and (e)). (d) The dotted lines show the best global
t  as in (d), using the “bivalent analyte model”. (For interpretation of the references
les). The data set “IgG after BSA” is more relevant than “only IgG
n FC1” because BSA is often used to passivate the chip surface
efore/during injection of samples (see Fig. 3). On mutant #3, bind-
ng of IgG amounted to 11 ± 5 RU after BSA and 27 ± 6 RU without
SA treatment, corresponding to 0.4% or 1% of an IgG monolayer,
espectively [12]. Only a small amount of lysozyme was  adsorbed
n any avidin mutant (Fig. S3), due to the high pI value of lysozyme
11.2 [13]).
.3. Biological interaction analysis on avidin
utant-functionalized chip surfacesIn a preceding study [6] we showed that biotinylated protein G
nd human IgG2 provide for a critical functional test of chip per-
ormance, for two reasons: (i) the interaction is multivalent in the M BSA in PBS 7.3). Double referencing [6,14] was used to obtain the experimental
the Langmuir model to the experimental binding curves (solid lines). (e) Analogous
lor in this ﬁgure legend, the reader is referred to the web version of this article.)
sense that one soluble IgG molecule is captured by two biotinylated
protein G molecules on the chip surface (Fig. 3a). (ii) In this case, the
repeated removal of IgG after each IgG injection (Fig. 3c) is typically
performed with 100 mM glycine buffer (pH 2.7, GE Healthcare Data
File 18-1012-91 AC, entitled “Afﬁnity Chromatography: Protein G
Sepharose 4 Fast Flow”, available at the internet from https://www.
gelifesciences.com/gehcls images/GELS/Related%20Content/Files/
1314774443672/litdoc18101291AC 20110831095008.pdf) which
seems dangerously close to “rigorous regeneration” (Fig. 1a) with
SDS/citric acid.
In Ref. [6] it was  shown that the biotin–avidin–biotin bridges
formed by mutant #1 were only affected by SDS/citric acid (pH
2.0) but not by glycine (pH 2.7). We now show that the same is
also true for mutants #2 (Fig. S4c) and #3 (Fig. 3c). The avidin
mutant under inspection was immobilized in both ﬂow cells, FC2
650 D. Zauner et al. / Sensors and Actuators B 229 (2016) 646–654
Fig. 4. Test for speciﬁc hybridization and non-speciﬁc adsorption of single-stranded DNA on mutant #5. (a) Schematic for hybridization of unlabeled analyte DNA, as used in
(  of unlabeled analyte DNA with complementary biotin-DNA which had been immobilized
o ent as in (d), using digoxigenin-labeled analyte (compare (a) and (b)). (For interpretation
o sion of this article.)
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Table 1
Fit parameters of the Langmuir model (dotted curves in Fig. 3d) and of the biva-
lent  analyte model (dotted curves in Fig. 3e) by which binding of human IgG2
towards immobilized biotin–protein G (Fig. 3a) was  analyzed on top of mutant #3.
The  corresponding data for mutant #2 are from Fig. S4, those for mutant #1 from
Ref. [6].
Mutant #1 #2 #3 #1–3
Langmuir model
10−5 ka M s 4.1 4.1 4.2 4.1 ± 0.1
104 kd s 11 7.4 8.4 9.0 ± 1.9
KD/nM 2.7 1.8 2.0 2.2 ± 0.5
Rmax/RU 1370 1360 1290 1340 ± 44
Bival. analyte model
10−5 ka1 M s 1.8 1.6 1.8 1.7 ± 0.1
104 kd1 s 17 14 14 15 ± 0.3
KD1/nM 9.4 8.8 7.5 8.6 ± 0.9
104 ka2 RU s 1.7 2.7 3.1 2.5 ± 0.7
kd2 s 0.013 0.013 0.017 0.014 ± 0.003c).  (b) Analogous schematic with digoxigenin-labeled analyte DNA. (c) Hybridization
n  mutant #5 in FC2 only (blue trace). (d) Segment from (c). (e) Analogous experim
f  the references to color in this ﬁgure legend, the reader is referred to the web  ver
as blocked with biotin–BSA (Fig. 3b) and FC1 was  functionalized
ith biotin–protein G (Fig. 3a). After further passivation of both
ow cells with biotin–BSA and BSA, different concentrations of
gG2 were injected and repeatedly removed with glycine (pH 2.7),
s shown in Fig. 3c. FC2 was  subtracted from FC1 and the resulting
race for sample buffer injection (Fig. 3c) was subtracted from all
ther injection traces (“double referencing method” [14]), result-
ng in the experimental binding curves (solid traces in panels (d)
nd (e), Figs. 3 and S4). The kinetic data could well be ﬁtted by the
bivalent analyte model” (Figs. 3 e and S4e, dotted lines), which
ssumes binding of each IgG molecule by two adjacent protein G
olecules on the chip surface (Fig. 3a), in contrast to the simple
angmuir model (Figs. 3 d and S4d, dotted lines) which assumes
:1 binding.
The usefulness of all three avidin mutants (#1–3) for biological
nteraction analysis is proven by the good agreement of the cal-
ulated kinetic constants (Table 1), yielding averages with small
tandard deviations (last column). In spite of the less perfect ﬁt,
he Langmuir model has the advantage that it yields an effective Kd
alue with the usual dimension “nM” (not “RU”, as in the bivalent
nalyte model, see Table 1), allowing for comparison with liter-
ture data. Kd = 710 nM was reported from afﬁnity adsorption of
ixed human IgG [15]. The Fc fragment of human IgG1 gave Kd
alues of 47 nM in BIAcore experiments on a CM5  chip [16] and
10 nM in a homogeneous ﬂuorescence assay [17]. The discrepancy
ith Kd = 2 nM in Table 1 is in part explained by the fact that biva-
ent interaction was only possible on our dense avidin monolayers
hich allow for close proximity of immobilized biotin–protein G
Fig. 3a). Obviously our chip is able to mimic  the natural function
f protein G, which is also present at high lateral density on the
urface of Streptococcus sp. [18].KD2/RU 77 47 56 60 ± 15
Rmax/RU 1800 1930 1740 1820 ± 100
3.4. Sensitivity of avidin mutant-functionalized chips to acid or
SDS
As mentioned above, the selective removal of IgG from protein
G by 100 mM glycine (pH 2.7) in Fig. 3c seems rather close to the
SDS/citric acid mixture (pH 2.0, Fig. S5) used for removal of all
proteins at the end of Fig. 3c. A close look at the ﬁrst IgG2 injec-
tion indeed shows that the subsequent injection of glycine (pH 2.7)
leads to a lower baseline (−188 RU) than before injection of 200 nM
IgG2. Probably a small fraction of mutant #3 is more sensitive to
pH 2.7 than the rest, being bound to only one biotin residue on
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he biotin–SAM [19]. However, such baseline drift was not seen in
he subsequent cycles with lower concentrations of IgG2. Thus,
uch a baseline shift during the bait–prey interaction study can
asily be avoided when applying a dummy  injection of glycine (pH
.7) before the ﬁrst injection of IgG2. The same observations were
ade with mutants #1 [6] and #2 (Fig. S4c).
Unfortunately, pH 2.7 is insufﬁcient for removal of antigens from
mmobilized antibodies (or vice versa). Reported regeneration con-
itions range from pH 2.5 to pH 1.75 [1]. We,  therefore, examined
he resistance of the chip-bound avidin mutants #1–5 to low pH,
sing 2.5% citric acid without salt (pH 2.0) or with 150 mM NaCl
pH 1.9, Fig. S5). The results are shown in Figs. S6–S9. At pH 2,
nly mutant #1 showed stable binding to the biotinylated chip (red
quares in Fig. S7b). Fortunately, the sensitivity to pH 2 was  only
een if the avidin mutants were the only protein on the chip sur-
ace (state 2 in Fig. 1b). If biotinylated antibody was bound on top of
vidin (state 3 in Fig. 1b) then all ﬁve avidin mutants were resistant
o pH 2 (blue circles in Fig. S7b).
In spite of its lower pH (1.9, Fig. S5), the combination of citric acid
ith 150 mM NaCl caused much less removal of the avidin mutants
rom the biotinylated chip (Figs. S6–S9). A similar beneﬁcial effect
f elevated ionic strength is also expected for the 100 mM glycine
uffers typically used for antibody–antigen separation.
Detergents are also used for removal of prey from bait [1]. There-
ore, we tested the resistance of mutants #1–5 to 0.5% SDS at neutral
H (Figs. S10 and S11). Mutant #1 was very stable, while mutant
3 showed losses of ∼5% (irrespective of whether biotin–IgG was
ound on top of the avidin layer or not). Inclusion of NaCl afforded
ncreased resistance to SDS.
The reported experiments with citric acid, NaCl, and SDS
esulted in the following rules for “normal regeneration” (Fig. 1a)
f chips functionalized with the tested avidin mutants:
i. The regeneration buffer (pH 1.9 or SDS) should have physiolog-
ical ionic strength (e.g., 150 mM NaCl) because then much less
avidin mutant (and biotinylated bait) is dissociated from the
chip.
ii. Mutant #3 is most attractive because of low nonspeciﬁc adsorp-
tion, but this mutant will resist pH 1.9 only if it is crosslinked
by a multiply biotinylated protein (sketch (d) in Fig. S7). Pro-
nounced stabilization of avidin by such crosslinking has been
demonstrated before [6]. This stabilization is high in case of
IgG carrying 6–7 biotin residues on average (blue circles in
Fig. S7b).
ii. The extent of crosslinking, and of stabilization at pH 1.9, will be
much weaker in case of small proteins with few biotin residues
and no stabilization is expected for baits with only one biotin
residue. The latter situation is equivalent to a simple avidin
monolayer (sketch (c) in Fig. S7). Here, only mutant #1 is sufﬁ-
ciently resistant to pH 1.9 (red squares in Fig. S7b). Fortunately,
it is possible to eliminate nonspeciﬁc adsorption of protein on
mutant #1 [6]. In case of DNA, however, it is necessary to use
mutant #3 and other methods than pH 1.9 for “normal regen-
eration” (see Section 3.6).
v. A small loss of avidin plus biotinylated bait will frequently
be expected during the ﬁrst regeneration round, even with
milder regeneration at pH 2.7 (Fig. 3). Fortunately, no such
loss is seen in subsequent injections. Therefore, a dummy
injection with regeneration buffer should be performed before
repeated binding and dissociation of prey molecules. Initial
removal of the weekly bound avidin molecules has no adverse
effects on subsequent measurement cycles of bait–prey interac-
tion.
In conclusion, the choice of regeneration conditions and the
hoice of mutant #1 versus #3 must be made with care, in order totors B 229 (2016) 646–654 651
exploit the full potential of these mutants for regenerative biosens-
ing.
3.5. How to prevent bait molecule immobilization in the
reference cell
Label-free biosensing requires injection of the sample in the
active cell with immobilized bait molecule and in a reference cell
lacking the bait molecules (see Fig. 3a,b). Fig. 3c (and Fig. S12c) show
that the bait (biotin–protein G) was  only present in the sample cell
if the reference cell was functionalized with biotin–BSA prior to
injection of biotin–protein G to the active cell. In contrast, pro-
nounced contamination of the reference cell with biotin–protein
G was  observed if protein G was  injected before biotin–BSA (Fig.
S12b). The reason lies in the design of microﬂuidic ﬂow cells which
allows for diffusion between the cells even if the ﬂow is blocked in
one cell (see Fig. S12a).
Fig. 4c shows another successful strategy by which bait immobi-
lization is restricted to the active cell. Mutant #5 was ﬁrst injected
into the active cell only (FC2, blue trace in Fig. 4c), followed by injec-
tion of biotinylated bait (biotin-probe). In this situation, mutant #5
is still absent in the reference cell (FC1, red trace) and no biotin-
DNA can be immobilized in FC1, even if a trace of it diffuses into
FC1. Subsequently, mutant #5 was  injected into the reference cell
(FC1, red trace), generating an inert surface where no DNA was
bound in the next steps.
The protocol in Fig. 4c always ensures restriction of bait to the
active ﬂow cell. The simpler protocol in Fig. 3c is only applicable
to large baits (such as proteins) which cannot bind on avidin after
injection of biotin–BSA.
3.6. Speciﬁc and nonspeciﬁc binding of DNA on
avidin-mutant-functionalized chip surfaces
In a preceding study [7], mutants #1 and #2 exhibited high
nonspeciﬁc adsorption of DNA, whereas only speciﬁc binding
(hybridization, Fig. 4a) was  seen on mutant #3. The same experi-
ment was  now performed on mutants #4 (Fig. S15) and #5 (Fig. 4c).
The sample cell was  functionalized with avidin and biotinylated
probe DNA, followed by avidin binding in the reference cell. Subse-
quently, absence of nonspeciﬁc protein adsorption was seen with
BSA and absence of nonspeciﬁc DNA adsorption when injecting
unlabeled probe DNA which had same nucleotide sequence as the
biotinylated DNA on the chip surface (Fig. 4c). Subsequent injec-
tion of unlabeled analyte DNA gave pronounced hybridization in
the sample cell (blue traces in Fig. 4c and d) and no nonspe-
ciﬁc response in the reference cell (red traces in Fig. 4c and d).
However, when the experiment was repeated using digoxigenin-
labeled DNA (Fig. 4b) in place of unlabeled DNA (Fig. 4a),
pronounced binding was observed in the reference cell (red trace
in Fig. 4e). No such effect was  seen with mutant #4 (Fig. S15) and
mutants #1–3 (see below) even when using digoxigenin-labeled
DNA.
Fig. 5 compares mutants #1–4 with respect to speciﬁc bind-
ing (hybridization) and nonspeciﬁc adsorption. The top row (a)–(c)
concerns experiments with mutant #1. Panel (a) shows pronounced
binding of analyte DNA, both in the active cell which contained
the complementary biotinylated probe DNA (blue trace), and in
the reference cell with the bare monolayer of mutant #1 (red
trace). We  suspected that the contribution of nonspeciﬁc DNA
adsorption in the active cell (blue trace) was  much lower than the
purely nonspeciﬁc signal in the reference cell (red trace), because
the positively charged mutant #1 was  covered with negatively
charged biotin-DNA in the active cell but not in the reference
cell. This hypothesis was veriﬁed in panel (b) where the refer-
ence cell contained a degenerated oligonucleotide (biotin-N19T),
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Fig. 5. DNA hybridization experiments performed on monolayers of mutant #1 (panels a–c), and of mutants #2, #3, and #4 (panels d–f), using the protocol of Fig. 4c. Red
traces  show adsorption of analyte DNA to the avidin mutants in FC1, blue traces the sum of speciﬁc and nonspeciﬁc binding in FC2 to avidin carrying biotin-labeled probe
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 digoxigenin label, except in (c). In (b) and (c) both ﬂow cells were treated with bio
his  ﬁgure legend, the reader is referred to the web version of this article.)
hile the active cell contained biotinylated probe DNA plus sub-
equently injected biotin-N19T. This resulted in low nonspeciﬁc
inding not only in the reference cell (red trace) but also in the
ctive cell (blue trace). Panel (c) conﬁrms the beneﬁcial effect
f biotin-N19T and a very minor contribution of the digoxigenin
abel to nonspeciﬁc adsorption of digoxigenin-labeled DNA to
utant #1.
The center row (d)–(f) shows the performance of mutants #2–4
nder the same conditions as used for mutant #1 in panel (a) (i.e.,
ith digoxigenin-labeled DNA, in absence of biotin-N19T). Nonspe-
iﬁc binding of DNA on mutant #2 (red trace in (d)) was  only slightly
ower than on mutant #1. Nonspeciﬁc DNA adsorption was  absent
n mutants #3 and #4 (red traces in (e) and (f)). The small tran-
ient displacement of the red trace in panel (f) is due to a bulk effect
different refractory index of sample and running buffer). The ﬁnd-
ngs are well explained by the high pI values of mutants #1 and #2
Fig. 1e), which implies a positive net charge, and by the neutral pI
f mutants #3 and 4, which eliminates electrostatic attraction of
NA.
The bottom row (g)–(i) shows the extent of speciﬁc binding
hybridization), as calculated by subtraction of nonspeciﬁc binding
n the reference cell (red traces in (d)–(f)) from total DNA binding in
he active cell (blue traces in (d)–(f)). The biphasic curve for mutant
2 (panel (g)) is caused by much higher nonspeciﬁc adsorption in
he reference cell than in the active cell (as explained above for
utant #1). In contrast, panels (h) and (i) reﬂect the true hybridiza-
ion signals on mutants #3 and #4, due to absence of nonspeciﬁcrom the blue traces in (d), (e), and (f), respectively. The analyte DNA always carried
19T before injection of analyte DNA. (For interpretation of the references to color in
adsorption on both mutants (red traces in (e) and (f)). Mutant
#3 exhibits a higher binding capacity than mutant #4, there-
fore it appears best suited for measurement of DNA-containing
samples.
In this study we  provide no method for the “normal regen-
eration” (Fig. 1a) of DNA-functionalized chips, i.e., for complete
dissociation of analyte DNA without loss of biotinylated DNA.
Mutant #3 is not sufﬁciently stable to use 100 mM HCl (as used
in the “Biotin CAPture Kit”) and the more acid-resistant mutant
#1 strongly adsorbs DNA. The most promising reagent seems con-
centrated urea; it ensures complete dissociation of DNA duplexes
[20], while avidin is known to resist 9 M urea without losing its
biotin-binding capacity [21]. However, establishing the exact con-
ditions will require a substantial amount of experiments in a future
study.
4. Conclusions
All ﬁve tested avidin mutants are suitable for reversible immo-
bilization of biotinylated baits on biotinylated sensor chips. The
stably formed biotin–avidin–biotin bridges can be quantitatively
dissolved when desired.
Mutant #1 showed the highest stability at pH 2 and the highest
binding capacity for biotinylated bait molecules. Nonspeciﬁc bind-
ing of proteins was  moderate, especially when biotin–BSA was  used
to passivate the reference cell and the unoccupied biotin-binding
sites in the active cell. The major weakness of mutant #1 was high
 Actua
n
b
n
f
a
t
e
r
b
s
c
s
o
f
a
D
a
p
b
l
t
r
A
(
(
e
S
m
A
t
R
[
[
[
[
[
[
[
[
[
[
[
[D. Zauner et al. / Sensors and
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or biological interaction analysis between puriﬁed proteins, but it
ppears unsuitable for biosensing where nucleic acids are likely
o be present. Mutant #2 resembles mutant #1 in all respects,
xcept that all positive and negative aspects are somewhat mode-
ated.
Mutant #3 showed slightly lower binding capacity and sta-
ility at pH 2, nevertheless it can well be used for interaction
tudies between antibodies and antigens where pH 2.3 is typi-
ally used for repeated removal of the analyte. The reason is that
tatistically biotinylated antibodies or antigens cause crosslinking
f mutant #3, which confers high stability down to pH 2. This
act is important because mutant #3 appeared ideal in all other
spects: it showed the lowest nonspeciﬁc binding of protein and
NA and the highest performance in chip recycling with SDS/citric
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